SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

3 Sep 2021 12:12

RNS Number : 7014K
Caledonia Investments PLC
03 September 2021
Β 

Caledonia Investments plc

Β 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

Β 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the Market Abuse Regulation of the following transactions in its ordinary shares of 5p ("Shares") involving two of its directors, Jamie Cayzer-Colvin and William Wyatt, and persons closely associated with Mr Cayzer-Colvin.

Β 

On 1 September 2021, The Simon Weinstock Will Trust, of which Mr Cayzer-Colvin is a trustee, sold 54,989 Shares in Caledonia, representing 0.1% of the Company's total issued ordinary share capital. The Shares were sold on market at a price of 3,385p each.

Β 

On 2 September 2021, Shares, as noted in the table below, were transferred to the above-named directors under Caledonia's 2011 Performance Share Scheme ("Performance Share Scheme") at nil cost. All Shares were sourced from The Caledonia Investments plc Employee Share Trust ("EST"):

Β 

Director

Performance Share Scheme

W P Wyatt

24,250

J M B Cayzer-Colvin

15,903

Β 

On the same date, Mr Wyatt sold 24,250 Shares back to the EST and Mr Cayzer-Colvin sold 15,903 back to the EST. All Shares were sold at 3,410p per Share.

Β 

Mr Wyatt's total interests in Shares following the above transactions are as follows:

Β 

Beneficial - 1,151,152 Shares* = 2.09%

Non-beneficial - 82,467 Shares = 0.15%

Performance share scheme awards - 123,076 Shares = 0.22%

Deferred bonus plan awards - 13,652 Shares = 0.02%

Β 

* includes 1,009,898 Shares owned by Dunchurch Lodge.

Β 

Mr Cayzer-Colvin's total interests in Shares following the above transactions are as follows:

Β 

Beneficial - 250,024 Shares** = 0.45%

Non-beneficial - 203,384 Shares** = 0.36%

Performance share scheme awards - 76,969 Shares = 0.14%

Deferred bonus plan awards - 10,050 Shares = 0.02%

Β 

** following a change to the status of persons closely associated with Mr Cayzer-Colvin, his previously reported beneficial interests have reduced by 124,889 Shares and his non-beneficial interests have increased by 108,100 Shares.

Β 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

Β 

Enquiries:

Richard Webster

Company Secretary

Tel: +44 20 7802 8080

Β 

3 September 2021

Β 

APPENDIX

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

William Penfold Wyatt

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Director/Chief Executive

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme awards ("PSS")

2. Sale of shares arising from above

Β 

Β 

c)

Β 

Β 

Price(s) and volume(s)

Β 

Β 

1. Exercise of PSS awards

Β 

2. Sale of shares

Β 

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

24,250

Β 

Β£34.10

24,250

Β 

d)

Β 

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

24,250 shares

Β 

Exercise of PSS awards (Β£nil)

Sale of shares: Β£34.10

Β 

e)

Β 

Date of the transaction

Β 

Β 

2 September 2021

f)

Β 

Place of the transaction

Β 

Exercise of PSS awards: London - outside a trading venue

Sale of shares: London Stock Exchange XLON

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

James Michael Beale Cayzer-Colvin

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Executive Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme awards ("PSS")

2. Sale of shares arising from above

Β 

Β 

c)

Β 

Β 

Price(s) and volume(s)

Β 

Β 

1. Exercise of PSS awards

Β 

2. Sale of shares

Β 

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

15,903

Β 

Β£34.10

15,903

Β 

d)

Β 

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

Β 

15,903 shares

Β 

Exercise of PSS awards (Β£nil)

Sale of shares: Β£34.10

e)

Β 

Date of the transaction

Β 

Β 

2 September 2021

f)

Β 

Place of the transaction

Β 

Exercise of PSS awards: London - outside a trading venue

Sale of shares: London Stock Exchange XLON

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

The Simon Weinstock Will Trust

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Person closely associated with James Cayzer-Colvin, a director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Sale of ordinary shares

Β 

c)

Β 

Β 

Price(s) and volume(s)

Β 

Β 

Sale

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£33.85

54,989

Β 

d)

Β 

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

n/a single tranaction

e)

Β 

Date of the transaction

Β 

Β 

1 September 2021

f)

Β 

Place of the transaction

Β 

London Stock Exchange XLON

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBBGDCBBGDGBX
Date   Source Headline
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 202411:29 amRNSNet Asset Value(s)
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20244:00 pmRNSAnnual Financial Report
7th Jun 20245:22 pmRNSDirector/PDMR Shareholding
6th Jun 20243:28 pmRNSDirector/PDMR Shareholding
6th Jun 20249:39 amRNSNet Asset Value(s)
30th May 20242:55 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFinal Results
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.